semaglutide long term safety GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Semaglutide, also known as Ozempic,

With weight loss, breast density can appear to increase, and this could mask detection of breast cancer on mammography and may also prompt additional false alarms for findings that are not cancer

PubMed laboratory research record [PMID: 39212900] PubMed record related to this compound for laboratory literature review

By end user, the homecare settings segment dominated the market with a share of 64% in 2025 and is expected to grow at the fastest CAGR of 15.1% in the coming years

Sesame said the GLP-1s can be between $950 and $1,600 a month, which may not be covered by insurance

Challenges in detecting disease modification in Parkinsons disease clinical trials